Canada Veterinary Cardiology Market

Canada Veterinary Cardiology Market Insights Forecasts to 2035

• The Canada Veterinary Cardiology Market Size was estimated at USD 180.36 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.18% from 2025 to 2035
• The Canada Veterinary Cardiology Market Size is Expected to Reach USD 386.74 Million by 2035

According to a research report published by Decisions Advisors, The Canada Veterinary Cardiology Market is Anticipated to Reach USD 386.74 Million by 2035, Growing at a CAGR of 7.18% from 2025 to 2035. The rising incidence of heart disease in pets and improvements in diagnostic and treatment tools are driving the market's notable expansion. Further, one major factor driving the veterinary cardiology sector with the high incidence of cardiologic disorders in companion animals, especially dogs.

Market Overview

The Canadian veterinary cardiology market refers to the industry focused on the diagnosis, management, and treatment of cardiac diseases in animals, mostly companion animals like dogs and cats, as well as production animals like cattle are the main focuses. Further, to identify and treat conditions like congestive heart failure, arrhythmias, myocardial diseases, and congenital heart defects, it uses specialised services, pharmaceutical products, and cutting-edge diagnostic technologies. Also, rising pet ownership, increased knowledge of animal cardiovascular health, technological developments in veterinary cardiology, and easier access to veterinary specialists are factors that affect the Canadian market. Besides making advanced cardiac care more affordable, the increase in pet insurance coverage contributes to market expansion. Also, infrastructure and research investments in veterinary healthcare are made by the public and private sectors.

According to statistics, about 10% of dogs seen in primary care have cardiac conditions; for older dogs, this number jumps to over 60%. Most canine heart disease cases are caused by myxomatous mitral valve disease (MMVD), particularly in small and elderly dog breeds. Veterinary cardiology services and medication are in high demand due to congestive heart failure (CHF), which is frequently brought on by dilated cardiomyopathy and valvular disorders.

Report Coverage

This research report categorises the market for the Canada veterinary cardiology market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Canada veterinary cardiology market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Canada veterinary cardiology market.

Driving Factors

A primary key factor is the growing incidence of heart diseases in companion animals, especially dogs, leading to a heightened need for specialised diagnostic tools and therapies. The industry gains from increasing pet ownership, heightened awareness among pet owners regarding preventive healthcare, and growing investments in veterinary healthcare facilities, which influence the novel market expansion. Further, innovations in technology, including AI-driven diagnostics, wearable heart monitors, and less invasive surgical methods, enhance early detection of diseases and treatment accuracy, driving market expansion. The growth of specialised veterinary cardiology clinics and the incorporation of telemedicine for remote heart consultations enhance access to advanced care, boosting the market growth. Moreover, as a result, Canada is acknowledged as the North American market with the fastest rate of growth for veterinary cardiology.

Restraining Factors

The high expense of sophisticated veterinary cardiology procedures and equipment is a major obstacle that may prevent many pet owners from affording or using them. The difficulty of treating chronic cardiac diseases in animals, which necessitate constant observation, strict adherence to medication schedules, and frequent veterinary checkups, is another significant obstacle that may impact treatment compliance and results.

Market Segmentation

The Canada veterinary cardiology market share is classified into product and indication.

• The pharmaceuticals segment dominated the market in 2024 and is projected to grow at a significant CAGR during the forecast period.

The Canada veterinary cardiology market is divided by product into pharmaceuticals, diagnostics, Among these, the pharmaceuticals segment dominated the market in 2024 and is projected to grow at a significant CAGR during the forecast period. This segment growth is fueled by the rising incidence of cardiac disorders in pets, which include valvular disorders, arrhythmias, and congestive heart failure. Pets who live longer thanks to better nutrition and healthcare are more likely to experience age-related cardiac problems, which is driving up demand for pharmaceutical treatments. Moreover, improvements in veterinary medicine have also improved diagnostics and raised pet owners' awareness of the significance of an animal's heart health.

• The congestive heart failure segment held a substantial market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Canada veterinary cardiology market is segmented by indication into congestive heart failure, myocardial (heart muscle) disease, arrhythmias, and other indications. Among these, the congestive heart failure segment held a substantial market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the rise in dilated cardiomyopathy, and valvular heart disease is the cause of this growth. These conditions cause either volume overload, pressure overload, or both, which eventually lead to CHF, and enlargement of the heart chambers and impaired contractility, which lead to poor cardiac function and ultimately CHF, respectively. This segment is growing as a result of ongoing research and improvements in the treatment of CHF.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the Canada veterinary cardiology market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Trillium Veterinary Cardiology
• East Coast Veterinary Cardiology
• Vetster
• Wilder Harrier
• Grey Wolf Animal Health
• Others

Recent Developments:

• In October 2022, Boehringer Ingelheim Animal Health Canada Inc. played a key role in supporting the creation of the Centre of Excellence in Veterinary Interventional Medicine and Cardiology at CHUV. Boehringer Ingelheim Animal Health Canada has contributed funds to the purchase of interventional cardiology equipment for use at CEMIP in support of improving animal health by encouraging minimally invasive procedures and educating students.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Canada, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the Canada veterinary cardiology Market based on the below-mentioned segments:

Canada Veterinary Cardiology Market, By Product

• Pharmaceuticals
  • Pimobendan
  • Spironolactone and benazepril hydrochloride
  •  Other pharmaceuticals
• Diagnostics
  • Physical exam
  • Chest X-rays
  • Electrocardiogram (ECG)
  • Other diagnostics

Canada Veterinary Cardiology Market, By Indication

• Congestive heart failure
• Myocardial (heart muscle) disease
• Arrhythmias
• Other indications